Skip to Content
MilliporeSigma
Search Within
Document Type

100-84-5

Applied Filters:
Keyword:'100-84-5'
Showing 1-30 of 1004 results for "100-84-5" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
102 55 106 53 85 101 95 100 95 103 88 82 81 98 91 84 21 128 89 98 98 99 103 38 99 76 97 102 90 101 115 117 92 100 103 92 96
NovAseptic® Valve Actuator/Diaphragm Installation Guide
NA 12/84 NA 18/84 NA 25/84 NA 38/84 NA 51/84 NA 76/84 65 www.millipore.comwww.millipore.com 7 8 PTFE Diaphragm 432 NA 12/84 8-9Nm
The Effective Use of Protein Kinase Inhibitors
103 38 99 76 97 102 90 101 115 117 92 100 103 92 96 101 83 84 79 13 21 100 70 86 102 105 100 94 88 104 104 102 81 88 98 91 104 117
NovaSeptum®GO Conical Tube Sampling Unit
4 11 9 6 7 2 3 7 7 5 6 10 84 7 5 10 6 4 4 2
Data Sheet - P6862
EDTA, 2 mM EGTA, 5 mM DTT, 250 mM NaCl, 0.05% TRITON X-100, and 50% glycerol. Preparation Instructions Prepare stock solutions in 10 mM HEPES, pH 7.4, 5 mM DTT, 0.01% TRITON X-100. Storage/Stability
User Guide-RAB0511
Cell Culture Supernatants 98 84-103 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 96 95 96 Range (%) 84-103 83-103 84-104 1:4 Average % of Expected
User Guide-RAB0043
Plasma 93 84-103 Cell Culture Supernatants 95 83-104 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 93 92 94 Range (%) 84-104 83-104 84-104 1:4
Spec sheet: NovAseptic® Valve, DIAPHRAGM, PTFE
Lit. No. NA12/25 NA12/84 SP1009EN00 NA18/25 NA18/84 SP1009EN00 NA25/25 NA25/84 SP1009EN00 NA38/25 NA38/84 SP1009EN00 NA51/25 NA51/84 SP1009EN00 NA76/25 NA76/84 SP1009EN00 ** Note: Use
NovAseptic Valve: Diaphragm, PTFE
Lit. No. NA12/25 NA12/84 SP1009EN00 NA18/25 NA18/84 SP1009EN00 NA25/25 NA25/84 SP1009EN00 NA38/25 NA38/84 SP1009EN00 NA51/25 NA51/84 SP1009EN00 NA76/25 NA76/84 SP1009EN00 ** Note: Use
Product Information Sheet - SAE0192
Reagent Parathyroid Hormone 1-84 (full length) Human Recombinant produced in E. coli is a single, non-glycosylated, polypeptide chain that contains 84 amino acids (MW of ~9.4 kDa), with the
Data Sheet - P9542
EGTA, 5 mM DTT, 250 mM NaCl, 0.05% TRITON X-100, and 50% glycerol. Activity is measured in a mixture containing 20 mM HEPES, pH 7.4, 10 mM MgCl2, 100 µM CaCl2, 500 µM ATP, lipid mix (100 µg/ml
Product Information Sheet -SRP3096
not recommended. References 1. Billiau, A., Immunol. Today, 8, 84 (1987). 2. Gauldie, J., et al., Proc. Natl. Acad. Sci. USA, 84, 7251 (1987). 3. Van Snick, J., Ann. Rev. Immunol., 8, 253 (1990
Data Sheet - P0540
EDTA, 2 mM EGTA, 5 mM DTT, 250 mM NaCl, 0.05% Triton X-100, and 50% glycerol. Preparation Instructions Dilutions can be made in 10 mM HEPES (pH 7.4), 5 mM DTT, 0.01% Triton X-100. Storage/Stability
User Guide-RAB0303
Human IL-5 into the sample types listed below. Mean recoveries are as follows: Sample Type Average % Recovery Range (%) Serum 95 83-103 Plasma 96 84-104 Cell Culture Supernatants 95 84-103
User Guide-RAB0032
Plasma 95 84-103 Cell Culture Supernatants 94 84-107 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 94 93 96 Range (%) 85-104 84-106 87-105
User Guide-RAB0079
:2 Average % of Expected 94 93 94 Range (%) 83-103 82-105 84-106 1:4 Average % of Expected Range 95 93 96 Range (%) 84-105 83-103 84-105 4 RAB0079pis Rev 08/24
User Guide-RAB0298
Plasma 96 84-104 Cell Culture Supernatants 101 85-106 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 94 95 97 Range (%) 83-102 84-104 84-103 1:4
User Guide-RAB0216
104 Cell Culture Supernatants 96 84-105 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 95 94 94 Range (%) 83-103 84-105 85-105 1:4 Average % of Expected
User Guide-RAB0093
Cell Culture Supernatants 95 84-104 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 93 92 94 Range (%) 84-103 83-105 84-105 1:4 Average % of Expected
User Guide-RAB0306
Plasma 94 84-104 Cell Culture Supernatants 96 83-105 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 95 96 97 Range (%) 84-103 85-105 84-105 1:4
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
-6 FGF21 Musclin Average +std 3 100 96 105 71 90 95 109 95 97 105 119 84 100 82 106 +std 4 92 104 113 77 90 101 105 128 93 115 114 77 130 92
Product Information Sheet - RAB0058
83-103 84-104 1:4 Average % of
Product Information Sheet - SE120041
Serum Original Value (mg/L) Percentage of Recovery 1:2 1:4 1:8 1 0.032 94 100 100 2 0.041 93 88 117 3 0.095 84 84 82 References 1. Schultz, D.R., and Arnold, P.I., Properties of four acute
User Guide-RAB0461
Expected Range 96 97 95 Range (%) 85-104 84-102 85-103 5 RAB0461pis Rev 08/24 Reproducibility Intra-Assay CV%: <10% Inter-Assay CV%: <12% Specificity This ELISA kit shows no cross-reactivity
Data Sheet - P8538
mM EDTA, 2 mM EGTA, 5 mM DTT, 250 mM NaCl, 0.05% TRITON X-100, and 50% glycerol. Activity is measured in a mixture containing 20 mM HEPES, pH 7.4, 10 mM MgCl2, 100 µM EGTA, 100 µM ATP, lipid
User Guide-RAB1191
Serum 95 84-104 Plasma 90 84-101 Cell Culture Supernatants 113 108-119 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 89 92 100 Range (%) 84-93 89-
User Guide-RAB0751
Cell Culture Supernatants 84 74-94 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 83 97 92 Range (%) 75-91 89-103 84-100 1:4 Average % of Expected
User Guide-RAB0114
Plasma 93 84-105 Cell Culture Supernatants 93 83-104 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 92 94 93 Range (%) 83-102 84-103 83-104
In Solution! Product Flyer
(IC50 = 5 nM). 500 µg 63 Insolution™ GsK-3β Inhibitor VIII (aR-ao14418) 361557 25 mM in dMso a cell-permeable, potent, atP-competitive inhibitor of GsK-3β (IC50 = 104 nM). 5 mg 84 Insolution
Bulletin - 768979
99,95 Vol.-% Impurities O2 100 40 ppmv CO2 5 ppmv H2O
Page 1 of 34